Material Information- Clarification of Media Report
1.Date of occurrence of the event: 2026/05/11
2.Company name: Handa Pharmaceuticals, Inc.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”): Head office
4.Reciprocal shareholding ratios: NA.
5.Name of the reporting media: Economic Daily News
6.Content of the report: According to market analysts ……The market estimates that Handa’s EPS will reach NTD 4 this year. With the full-year contribution from HND-039, the company is expected to earn more than one share capital next year, with EPS reaching NTD 11.3.
7.Cause of occurrence: Clarification of media report.
8.Countermeasures: Handa Pharmaceuticals hereby clarifies as follows: The Company has not issued any financial forecast. Any information regarding the Company’s operations, revenue, or profitability should be based solely on the information publicly disclosed
by the Company on the Market Observation Post System (MOPS).
9.Any other matters that need to be specified: Drug development is a lengthy and costly process, and the timing of regulatory approvals remains uncertain. In addition, successful development and commercialization cannot be guaranteed. Investors are therefore advised to carefully evaluate the associated risks and refer to the information disclosed by the Company on the Market Observation Post System (MOPS).